Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-020873·AVENUE THERAPEUTICS, INC.
Schedule 13G ownership disclosure
AVENUE THERAPEUTICS, INC.
Common Stock · CUSIP: 05360L403
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ikarian Capital, LLC
Shares: 140,000 · Class: 6.8%
- Neil Shahrestani
Shares: 140,000 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020873
- Form type
- SCHEDULE 13G
- Filer
- AVENUE THERAPEUTICS, INC.
- CIK
- CIK 1644963
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership